News
Article
Author(s):
The company is showcasing its lasers at the Hawaiian Eye and Retina 2024 meeting, being held January 13-19 at the Grand Wailea Resort in Maui.
Iridex Corp announced the US launch of its next-generation platform Iridex 532 and Iridex 577 lasers alongside its 35th-anniversary celebration.
The announcement was made ahead of the company’s official showcase at the Hawaiian Eye and Retina 2024 meeting on January 13-19, 2024, at the Grand Wailea Resort in Maui.
According to a news release, both lasers harness multiple treatment modes including continuous-wave and Iridex’ patented MicroPulse Technology and an intuitive touchscreen interface providing a wide range of clinical control options and features to optimize the treatment of retinal disorders and glaucoma.
“The launch of the new Iridex 532 and Iridex 577 Lasers stands as a testament to our 35-year heritage of providing advanced laser solutions to ophthalmologists worldwide,” David Bruce, President and CEO of Iridex, said in the news release.“These innovations mark a pivotal moment for us, blending modern technology with user-centric design to ensure optimized treatments for retinal disorders and glaucoma.”
After previewing the new Iridex 577 nm laser, Sam Mansour, MD, medical director of the Virginia Retina Center, said in the news release he was very pleased with the compact design and intuitive user interface.
“Its treatment-session recordings enhance therapeutic tracking from subsequent laser sessions, and the rapid maneuverability between console menus will undoubtedly improve patient flow,” he said in the news release. “Having used Iridex laser systems for 30 years, I can attest to the highly dependable quality of their products."
According to the company, key points of the lasers include: